OBJECTIVE: To determine if functional polymorphisms of folate/homocysteine pathway enzymes are associated with homocysteine concentrations and/or coronary artery calcification (CAC) scores in patients with systemic lupus erythematosus (SLE) and controls. METHODS: We investigated 163 SLE patients and 160 controls. Functional polymorphisms in 6 genes in the folate/homocysteine pathway were genotyped: 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C>T, MTHFR 1298A>C, cystathionine ss-synthase (CBS) 844ins68, methionine synthase (MTR) 2756A>G, methionine synthase reductase (MTRR) 66A>G, thymidylate synthase (TYMS) 1494del6, and dihydrofolate reductase (DHFR) c.86+60_78. RESULTS: Homocysteine levels were higher in African American SLE patients than Caucasian patients and African American controls. Genotype distributions were significantly different in African American and Caucasian controls for 6 of the 7 polymorphisms. Genotype distributions for each polymorphism did not differ significantly between SLE patients and controls even after stratification by race. Glomerular filtration rate was strongly negatively correlated to homocysteine levels, and was therefore adjusted for as a covariate in the models of the effects of the polymorphisms on homocysteine levels. In SLE patients none of the 7 polymorphisms was associated with homocysteine concentrations. In Caucasian controls only MTHFR 677C>T and 1298A>C showed effects on homocysteine similar to what would be expected from the literature. There were no genotypic associations with median CAC scores in SLE patients or controls with and without stratification by race. CONCLUSION: Polymorphisms in folate/homocysteine metabolizing enzymes do not predict higher homocysteine levels or CAC scores in patients with SLE.
OBJECTIVE: To determine if functional polymorphisms of folate/homocysteine pathway enzymes are associated with homocysteine concentrations and/or coronary artery calcification (CAC) scores in patients with systemic lupus erythematosus (SLE) and controls. METHODS: We investigated 163 SLEpatients and 160 controls. Functional polymorphisms in 6 genes in the folate/homocysteine pathway were genotyped: 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C>T, MTHFR 1298A>C, cystathionine ss-synthase (CBS) 844ins68, methionine synthase (MTR) 2756A>G, methionine synthase reductase (MTRR) 66A>G, thymidylate synthase (TYMS) 1494del6, and dihydrofolate reductase (DHFR) c.86+60_78. RESULTS:Homocysteine levels were higher in African American SLEpatients than Caucasian patients and African American controls. Genotype distributions were significantly different in African American and Caucasian controls for 6 of the 7 polymorphisms. Genotype distributions for each polymorphism did not differ significantly between SLEpatients and controls even after stratification by race. Glomerular filtration rate was strongly negatively correlated to homocysteine levels, and was therefore adjusted for as a covariate in the models of the effects of the polymorphisms on homocysteine levels. In SLEpatients none of the 7 polymorphisms was associated with homocysteine concentrations. In Caucasian controls only MTHFR 677C>T and 1298A>C showed effects on homocysteine similar to what would be expected from the literature. There were no genotypic associations with median CAC scores in SLEpatients or controls with and without stratification by race. CONCLUSION: Polymorphisms in folate/homocysteine metabolizing enzymes do not predict higher homocysteine levels or CAC scores in patients with SLE.
Authors: S Manzi; E N Meilahn; J E Rairie; C G Conte; T A Medsger; L Jansen-McWilliams; R B D'Agostino; L H Kuller Journal: Am J Epidemiol Date: 1997-03-01 Impact factor: 4.897
Authors: I M Graham; L E Daly; H M Refsum; K Robinson; L E Brattström; P M Ueland; R J Palma-Reis; G H Boers; R G Sheahan; B Israelsson; C S Uiterwaal; R Meleady; D McMaster; P Verhoef; J Witteman; P Rubba; H Bellet; J C Wautrecht; H W de Valk; A C Sales Lúis; F M Parrot-Rouland; K S Tan; I Higgins; D Garcon; G Andria Journal: JAMA Date: 1997-06-11 Impact factor: 56.272
Authors: G Pepe; O C Vanegas; O Rickards; B Giusti; P Comeglio; T Brunelli; R Marcucci; D Prisco; G F Gensini; R Abbate Journal: Hum Genet Date: 1999-02 Impact factor: 4.132
Authors: William G Johnson; Edward S Stenroos; John R Spychala; Sansnee Chatkupt; Sue X Ming; Steven Buyske Journal: Am J Med Genet A Date: 2004-02-01 Impact factor: 2.802
Authors: S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone Journal: Am J Hum Genet Date: 1985-01 Impact factor: 11.025
Authors: P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen Journal: Circulation Date: 1996-01-01 Impact factor: 29.690
Authors: Kala Y Kamdar; Kevin R Krull; Randa A El-Zein; Pim Brouwers; Brian S Potter; Lynnette L Harris; Suzanne Holm; Zoann Dreyer; Fernando Scaglia; Carol J Etzel; Melissa Bondy; M Fatih Okcu Journal: Pediatr Blood Cancer Date: 2011-05-25 Impact factor: 3.167
Authors: Rachel Kaiser; Yonghong Li; Monica Chang; Joseph Catanese; Ann B Begovich; Elizabeth E Brown; Jeffrey C Edberg; Gerald McGwin; Graciela S Alarcón; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vilá; Michelle A Petri; Robert P Kimberly; Kimberly E Taylor; Lindsey A Criswell Journal: J Rheumatol Date: 2012-06-15 Impact factor: 4.666
Authors: Carolyn M Summers; Laura E Mitchell; Anna Stanislawska-Sachadyn; Shirley F Baido; Ian A Blair; Joan M Von Feldt; Alexander S Whitehead Journal: Birth Defects Res A Clin Mol Teratol Date: 2010-08
Authors: R Robeva; D Tanev; S Andonova; M Nikolova; A Tomova; Ph Kumanov; A Savov; R Rashkov; Zl Kolarov Journal: Balkan J Med Genet Date: 2017-06-30 Impact factor: 0.519
Authors: Anna Stanisławska-Sachadyn; Joanna Borzyszkowska; Michał Krzemiński; Alicja Janowicz; Rafał Dziadziuszko; Jacek Jassem; Witold Rzyman; Janusz Limon Journal: PLoS One Date: 2019-04-02 Impact factor: 3.240
Authors: Mirna Gisel González-Mercado; Fernando Rivas; M Patricia Gallegos-Arreola; M Cristina Morán-Moguel; Mario Salazar-Páramo; Laura González-López; J Iván Gámez-Nava; J Francisco Muñoz-Valle; Ricardo Medina-Coss Y León; Anahí González-Mercado; Mario A Aceves; Nory O Dávalos; Agustín Macías-Chumacera; Ingrid P Dávalos Journal: Genet Test Mol Biomarkers Date: 2017-10-10